Deutsche Bank’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ANTX
ACA
Deutsche Bank's ANTX Position: Q3 2026 in Review
Deutsche Bank reduced its AN2 Therapeutics (ANTX) stake by 13% in Q3 2026, selling an estimated $17.7K and leaving 22,495 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #3303.
Deutsche Bank first reported a position in ANTX in Q2 2022 and has held it in 7 quarters since. The position peaked at $809K in Q4 2023. 88 funds tracked by Wall St. Rank hold ANTX as of Q3 2026.
- Deutsche Bank held 22,495 shares of AN2 Therapeutics worth $120K as of Q3 2026.
- Deutsche Bank sold 3,343 AN2 Therapeutics shares in Q3 2026, an estimated $17.7K.
- AN2 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3303 holding.
- Deutsche Bank first reported a position in AN2 Therapeutics in Q2 2022 and has held it in 7 quarters since.
- Deutsche Bank's AN2 Therapeutics position peaked at $809K in Q4 2023.
- 88 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.